STOCK TITAN

Becton Dickinson insider plans to sell 57 shares; Form 144 filed

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Becton, Dickinson and Company (BDX) filed a Form 144 for a proposed sale of 57 shares of common stock with an aggregate market value of $10,592.31. The planned sale is listed through Morgan Stanley Smith Barney LLC on the NYSE, with an approximate sale date of October 27, 2025.

The shares to be sold were acquired as Restricted Stock Units on August 20, 2025. Recent activity reported under a Rule 10b5-1 plan for Michael Feld includes 58 shares sold on September 26, 2025 for $10,499.74 and 57 shares sold on August 22, 2025 for $11,285.43.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Becton Dickinson & Co

NYSE:BDX

BDX Rankings

BDX Latest News

BDX Latest SEC Filings

BDX Stock Data

57.34B
283.68M
0.57%
92.26%
1.59%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
FRANKLIN LAKES